ONC Kronos AI forecast
A 30-trading-day price forecast for BeOne Medicines Ltd. American Depositary Shares (ONC) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts BeOne Medicines Ltd. American Depositary Shares at $344.63 on 2026-12-08, −5.9% from the last close of $366.05 on 2026-10-27. Eight out of ten sampled paths end between $329.50 and $371.46, and 2 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of ONC
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $373.74 | $363.24 | $392.55 |
| 2026-11-10 | $376.11 | $363.54 | $390.37 |
| 2026-11-17 | $377.49 | $363.71 | $387.07 |
| 2026-11-24 | $366.38 | $353.32 | $375.35 |
| 2026-12-01 | $363.87 | $346.97 | $376.56 |
| 2026-12-08 | $344.63 | $329.50 | $371.46 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for ONC?
- Kronos AI's median forecast for ONC is $344.63 in 30 trading days, −5.9% from the last close, with a 10–90% range of $329.50 to $371.46.
- Is the ONC Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC